设为首页 加入收藏

TOP

DEBERZA Tablets 20mg(Tofogliflozin Hydrate)
2015-04-20 21:16:52 来源: 作者: 【 】 浏览:1628次 评论:0
Brand name :
DEBERZA Tablets 20mg
 Active ingredient:
Tofogliflozin Hydrate
 Dosage form:
light yellow tablet with split line, diameter: approx. 6.1 mm, thickness: approx. 3.3 mm
 Print on wrapping:
デベルザ 20 mg, DEBERZA 20 mg, 122, 糖尿病用薬

Effects of this medicine

This medicine lowers blood glucose levels by acting on kidney and promoting the excretion of glucose into urine.
It is usually used to treat type II diabetes mellitus.

Before using this medicine, be sure to tell your doctor and pharmacist

  • If you have previously experienced any allergic reactions (itch, rash, etc.) to any medicines.
    If you have: ketosis, diabetic coma or precoma, infection or injury.
    If you are in the pre-/post-operative period.
  • If you are pregnant or breastfeeding.
  • If you are taking any other medicinal products. (Some medicines may interact to enhance or diminish medicinal effects. Beware of over-the-counter medicines and dietary supplements as well as other prescription medicines.)

Dosing schedule (How to take this medicine)

  • Your dosing schedule prescribed by your doctor is <<        to be written by a healthcare professional>>
  • In general, for adults, take 20 mg of tofogliflozin once a day, before or after breakfast. Strictly follow the instructions.
  • If you miss a dose, you should never take two doses at one time. Take the missed dose (one day's worth) as soon as possible. If it is almost time for the next dose, continue your regular dosing schedule.
  • If you accidentally take more than your prescribed dose, consult with your doctor or pharmacist.
  • Do not stop taking this medicine unless your doctor instructs you to do so.

Precautions while taking this medicine

  • Pay attention especially when you are engaged in dangerous activities such as working at heights and driving a car because development of hypoglycemia during such activities may lead to an accident. Carry a card stating that you are a diabetic patient. Carry sugar or glucose with you in preparation for hypoglycemia. If hypoglycemic symptoms occur while you are taking this medicine concomitantly with an alpha-glucosidase inhibitor (acarbose, voglibose, etc.), take the glucose.
  • This medicine may cause urinary-tract infection or genital infection. Pay attention and consult with your doctor in the event of onset.
  • This medicine may cause polyuria or frequent urination, leading to decrease in body fluid volume and dehydration. Try to drink an adequate amount of fluid. Pay attention to excessive decrease in body weight, as body weight may decrease.

Possible adverse reactions to this medicine

The most commonly reported adverse reactions include thirst and frequent urination. If any of these symptoms occur, consult with your doctor or pharmacist.
The symptoms described below are rarely seen as initial symptoms of the adverse reactions indicated in brackets. If any of these symptoms occur, stop taking this medicine and see your doctor immediately.
  • feeling of weakness, feeling of hunger, sweating [hypoglycemia]
  • fever, abdominal pain [pyelonephritis]
  • hyperventilation, conscious disorder, shivering fingers [dehydration]
The above symptoms do not describe all the adverse reactions to this medicine. Consult with your doctor or pharmacist if you notice any symptoms of concern other than those listed above.

Storage conditions and other information

  • Keep out of the reach of children. Store away from direct sunlight, heat and moisture.
  •  Discard the remainder. Do not store them.

Kowa Co., Ltd.Internal

Revised: 1/2015

The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It is important to minimize adverse reactions and maximize efficacy. To obtain a better therapeutic response, patients should understand their medication and cooperate with the treatment.

 
药物 Tofogliflozin Hydrate
活性成分(英文) Tofogliflozin Hydrate
商品名(英文) DEBERZA
治疗领域  
适应症 2型糖尿病
药理类别 选择性SGLT2抑制剂-2型糖尿病治疗药物
化学类型 1
审评分类  
给药途径 口服
剂型 片剂
规格 20mg
市场状态 处方药
公司 興和(株)
监管机构 pmda
批准日期 2014-03-01 
以下是“全球医药”详细资料
Tags: 责任编辑:admin
】【打印繁体】【投稿】【收藏】 【推荐】【举报】【评论】 【关闭】 【返回顶部
分享到QQ空间
分享到: 
上一篇Bonviva Injection 1mg(Ibandron.. 下一篇DEBERZA Tab(Tofogliflozin Hydr..

相关栏目

最新文章

图片主题

热门文章

推荐文章

相关文章

广告位